TY - JOUR
T1 - Stoppen is meestal niet nodig. Psoriasis en psoriasiforme reacties door geneesmiddelen
AU - Mulder, W. M. C.
AU - Meinardi, M. M. H. M.
AU - Bruynzeel, D. P.
PY - 2003/4/4
Y1 - 2003/4/4
N2 - Several drugs have been reported to precipitate or to exacerbate psoriasis. These drugs include lithium, beta adrenergic antagonists, antimalarials and non-steroidal anti-inflammatory drugs, in addition to an expanding list of various miscellaneous agents, including tetracycline. These cases occur mostly in patients with a history of psoriasis, although occasionally the new onset of psoriasis or a psoriasiform or pustular reaction has followed treatment with certain drugs. The effects are dose-dependent and pharmacologically based. Except in severe reactions, in case of absence of an alternative, the offending drug need not to be stopped.
AB - Several drugs have been reported to precipitate or to exacerbate psoriasis. These drugs include lithium, beta adrenergic antagonists, antimalarials and non-steroidal anti-inflammatory drugs, in addition to an expanding list of various miscellaneous agents, including tetracycline. These cases occur mostly in patients with a history of psoriasis, although occasionally the new onset of psoriasis or a psoriasiform or pustular reaction has followed treatment with certain drugs. The effects are dose-dependent and pharmacologically based. Except in severe reactions, in case of absence of an alternative, the offending drug need not to be stopped.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0037418816&origin=inward
M3 - Article
SN - 0031-6911
VL - 138
SP - 492
EP - 495
JO - Pharmaceutisch Weekblad
JF - Pharmaceutisch Weekblad
IS - 14
ER -